To get a product to patients fast, efficient clinical trial design has always been top-of-mind for drug developers. With new IP regulations and sustainability requirements being implemented, this will become more important than ever. Join this Johnson & Johnson Innovation – JLABS program as we hear from clinical innovation experts from Janssen R&D how new clinical trial designs are being explored based on new scientific insights.
Early innovators and entrepreneurs are welcome to register here https://jji.jnj/3ObJHju
They also welcome stakeholders supporting these startups.
